RIZATRIPTAN AH rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

rizatriptan benzoate

Darreichungsform:

Tablet, orally disintegrating

Zusammensetzung:

Excipient Ingredients: crospovidone; silicon dioxide; sodium stearylfumarate; mannitol; acesulfame potassium; colloidal anhydrous silica; ethylcellulose; hypromellose; Flavour

Verabreichungsweg:

Sublingual

Einheiten im Paket:

6, 3, 2

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

for acute treatment of migraine attacks with or without aura.

Produktbesonderheiten:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-03-20